Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04573530 · ClinicalTrials.gov registry record · NA
We Walk Plus Study for Older Adults With Intellectual Disabilities
A NA study of Intellectual Disability, sponsored by University of Illinois at Chicago.
- Active
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 2
- Study locations
NCT04573530: Active NA study of Intellectual Disability, sponsored by University of Illinois at Chicago.
NCT04573530 is a NA study of Intellectual Disability that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 46 participants, below the 352-participant average among 26 other Intellectual Disability trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04573530, a NA study of Intellectual Disability, is active but no longer recruiting, sponsored by University of Illinois at Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 2
- Study locations
Study Summary
Determine the feasibility and acceptability of We Walk Plus intervention to promote physical activity and improve cognition for older adults with intellectual disabilities (ID).
Primary Outcome
daily steps
Conditions Studied
Interventions
- BEHAVIORAL We Walk Plus Intervention
Study Locations (2)
Illinois
- University of Illinois at Chicago - Chicago
- Trinity Services Inc. - New Lenox
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-06-15 |
| Est. Completion | 2026-02-15 |
| Phase | NA |
What the registry record for NCT04573530 still lists
NCT04573530 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 352-participant average among 26 other Intellectual Disability trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Intellectual Disability appearing as the primary indexed condition, and to 1 intervention - of which We Walk Plus Intervention is the first listed.
NCT04573530 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04573530 about?
NCT04573530 is a clinical study titled "We Walk Plus Study for Older Adults With Intellectual Disabilities". Determine the feasibility and acceptability of We Walk Plus intervention to promote physical activity and improve cognition for older adults with intellectual disabilities (ID).
What is the current status of trial NCT04573530?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2021-06-15. Estimated completion is 2026-02-15.
What conditions does trial NCT04573530 study?
This clinical trial studies the following conditions: Intellectual Disability.
What interventions are being tested in trial NCT04573530?
The interventions under investigation include: We Walk Plus Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04573530?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04573530 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intellectual Disability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04573530's enrollment target sits among peer trials
46 21st of 26 higher than 6 of 26 other Intellectual Disability trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intellectual Disability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth
RECRUITING · NA
-
Online Learning Module to Advance Research Related to People With Disabilities
RECRUITING · NA
-
Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers
RECRUITING · NA
-
Harnessing Communication Preferences
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI